UNITEDHEALTH GROUP

(UNH)
  Report
Delayed Nyse  -  05/19 04:00:01 pm EDT
478.55 USD   +1.52%
05/18INSIDER SELL : Unitedhealth Group
MT
05/18UnitedHealth Group Announces Earnings Release Date
BU
05/16UnitedHealthcare Selected by State of Missouri to Serve Medicaid Beneficiaries
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 278 521332 732472 941442 235--
Enterprise Value (EV)1 308 214359 278495 037455 988446 168434 672
P/E ratio 20,5x21,9x27,8x22,7x19,8x17,4x
Yield 1,41%1,38%1,12%1,27%1,44%1,53%
Capitalization / Revenue 1,15x1,29x1,64x1,38x1,28x1,17x
EV / Revenue 1,27x1,40x1,72x1,42x1,29x1,15x
EV / EBITDA 13,8x14,2x18,3x14,9x13,0x11,3x
Price to Book 4,84x5,10x6,28x5,28x4,60x3,87x
Nbr of stocks (in thousands) 947 415948 821941 851938 172--
Reference price (USD) 294351502471471471
Announcement Date 01/15/202001/20/202101/19/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 242 155257 141287 597320 614346 520377 685
EBITDA1 22 40525 29627 07330 63534 20638 615
Operating profit (EBIT)1 19 68522 40523 97027 33730 73234 757
Operating Margin 8,13%8,71%8,33%8,53%8,87%9,20%
Pre-Tax Profit (EBT)1 17 98120 74222 31025 67629 09332 937
Net income1 13 83915 40317 28519 74522 42225 445
Net margin 5,71%5,99%6,01%6,16%6,47%6,74%
EPS2 14,316,018,120,823,827,1
Dividend per Share2 4,144,835,605,996,777,23
Announcement Date 01/15/202001/20/202101/19/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 72 33773 74380 14979 87780 13080 492
EBITDA1 6 5086 3127 7387 3807 7597 610
Operating profit (EBIT)1 5 7125 5416 9506 5926 9546 823
Operating Margin 7,90%7,51%8,67%8,25%8,68%8,48%
Pre-Tax Profit (EBT)1 5 2905 1106 5176 1746 4946 366
Net income1 4 0864 0715 0274 7235 0484 940
Net margin 5,65%5,52%6,27%5,91%6,30%6,14%
EPS2 4,284,265,274,975,325,22
Dividend per Share ------
Announcement Date 10/14/202101/19/202204/14/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 29 69326 54622 09613 7523 933-
Net Cash position1 -----7 563
Leverage (Debt / EBITDA) 1,33x1,05x0,82x0,45x0,11x-0,20x
Free Cash Flow1 16 39220 12319 88923 18523 33226 927
ROE (Net Profit / Equities) 25,7%24,9%24,1%25,3%25,4%25,0%
Shareholders' equity1 53 84861 85971 68778 03588 281101 806
ROA (Net Profit / Asset) 8,48%8,30%8,44%9,06%9,67%10,1%
Assets1 163 196185 589204 748217 859231 918251 934
Book Value Per Share2 60,868,880,089,3102122
Cash Flow per Share2 19,123,123,426,927,733,1
Capex1 2 0712 0512 4542 5242 8322 962
Capex / Sales 0,86%0,80%0,85%0,79%0,82%0,78%
Announcement Date 01/15/202001/20/202101/19/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 442 235 330 222
Net sales (USD) 287 597 000 000
Number of employees 350 000
Sales / Employee (USD) 821 706
Free-Float 99,4%
Free-Float capitalization (USD) 439 772 987 701
Avg. Exchange 20 sessions (USD) 1 623 637 393
Average Daily Capital Traded 0,37%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA